Recursion Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
RXRX
CUSIP
75629V104
All holders as of
Q4 2024
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 93 25.4 M $135 M
2024 Q4 338 305 M $2.06 B
2024 Q3 284 262 M $1.74 B
2024 Q2 288 255 M $1.91 B
2024 Q1 265 215 M $2.14 B
2023 Q4 213 211 M $2.08 B
2023 Q3 212 152 M $1.17 B
2023 Q2 166 128 M $953 M
2023 Q1 168 126 M $842 M
2022 Q4 152 132 M $1.02 B
2022 Q3 152 114 M $1.21 B
2022 Q2 138 106 M $861 M
2022 Q1 133 95.1 M $681 M
2021 Q4 133 94.6 M $1.62 B
2021 Q3 92 54.9 M $1.26 B
2021 Q2 80 47.0 M $1.71 B
2021 Q1 1 30.0 $1.00 k
2020 Q4 1 30.0 $1.00 k
2020 Q3 1 30.0 $1.00 k
2020 Q2 1 30.0 $1.00 k
2020 Q1 1 30.0 $1.00 k
2019 Q4 1 30.0 $1.00 k
2019 Q3 1 30.0 $1.00 k
2019 Q2 1 30.0 $1.00 k
2019 Q1 1 30.0 $1.00 k